Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 women.

MLA

Hagemann, Ian S., et al. “Mixed Clear Cell/Endometrioid and Clear Cell/Serous Carcinoma of the Uterus Are Clinicopathologically Similar to Pure Clear Cell Carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) Study of 311 Women.” Gynecologic Oncology, vol. 177, Oct. 2023, pp. 38–45. EBSCOhost, https://doi.org/10.1016/j.ygyno.2023.08.005.

APA

Hagemann, I. S., Deng, W., Zaino, R. J., Powell, M. A., Gunderson Jackson, C., Cosgrove, C., Mathews, C., Pearl, M. L., Waggoner, S., Ghebre, R., Lele, S., Guntupalli, S., Secord, A. A., Ioffe, O., Rasty, G., Singh, M., Soslow, R., Creasman, W., & Mutch, D. G. (2023). Mixed clear cell/endometrioid and clear cell/serous carcinoma of the uterus are clinicopathologically similar to pure clear cell carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) study of 311 women. Gynecologic Oncology, 177, 38–45. https://doi.org/10.1016/j.ygyno.2023.08.005

Chicago

Hagemann, Ian S., Wei Deng, Richard J. Zaino, Matthew A. Powell, Camille Gunderson Jackson, Casey Cosgrove, Cara Mathews, et al. 2023. “Mixed Clear Cell/Endometrioid and Clear Cell/Serous Carcinoma of the Uterus Are Clinicopathologically Similar to Pure Clear Cell Carcinoma: An NRG Oncology/Gynecologic Oncology Group (GOG-210) Study of 311 Women.” Gynecologic Oncology 177 (October): 38–45. doi:10.1016/j.ygyno.2023.08.005.